Suchergebnisse - "Brogan, Anita J"

PubPharm (28)

1

Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States

enthalten in: PharmacoEconomics | 2024

von Brogan, A. | Davis, A. | Mellott, C. | +3

2

Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States

enthalten in: PharmacoEconomics | 2024

von Brogan, A. | Davis, A. | Mellott, C. | +3

3

Targeted preventive vaccination campaigns to reduce Ebola outbreaks : An individual-based modeling study

enthalten in: Vaccine | 2023

von Bisanzio, D. | Davis, A. | Talbird, S. | +5

4

The Cost-Effectiveness and Budget Impact of Ibalizumab-uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United States

enthalten in: PharmacoEconomics | 2021

von Brogan, A. | Talbird, S. | Davis, A. | +2

5

The Cost-Effectiveness and Budget Impact of Ibalizumab-uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United States

enthalten in: PharmacoEconomics | 2021

von Brogan, A. | Talbird, S. | Davis, A. | +2

6

The Cost-Effectiveness and Budget Impact of Ibalizumab-uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United States

enthalten in: PharmacoEconomics | 2021

von Brogan, A. | Talbird, S. | Davis, A. | +2

7

The Cost-Effectiveness and Budget Impact of Ibalizumab-uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United States

enthalten in: PharmacoEconomics | 2021

von Brogan, A. | Talbird, S. | Davis, A. | +2

8

Short-term cost analysis of raltegravir versus atazanavir + ritonavir or darunavir + ritonavir for treatment-naive adults with HIV-1 infection in the United States

enthalten in: PloS one | 2018

von Brogan, A. | Davis, A. | Goodwin, B.

9

Short-term cost and efficiency analysis of raltegravir versus atazanavir/ritonavir or darunavir/ritonavir for treatment-naive adults with HIV-1 infection in Spain

enthalten in: HIV clinical trials | 2017

von Davis, A. | Brogan, A. | Goodwin, B. | +2

10

Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States : A dynamic transmission modeling approach

enthalten in: Human vaccines & immunotherapeutics | 2017

von Brogan, A. | Talbird, S. | Davis, A. | +2